Floatz logo

INTERFERON-ALFA-2A

Anus Neoplasms

protein_peptidePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Anus Neoplasms cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Jessa Hospital
Phase 4BB
v503
Merck Sharp & Dohme LLC
Phase 3BB
Capecitabine
Blokhin's Russian Cancer Research Center
Phase 3B
MITOMYCINS
Blokhin's Russian Cancer Research Center
Phase 3B
Aijp (Arnebia Indigo Jade Pearl)
University of California, San Francisco
Phase 2B

View all 14 →

Same molecule, other indications

INTERFERON-ALFA-2A is also rated in:

renal cell carcinomaDormant
BB
Indicative ·
71 / 100
View asset →
acute lymphoblastic leukemiaDormant
BB
Indicative ·
64 / 100
View asset →
kidney cancerDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →